Match!
The Lancet Diabetes & Endocrinology
IF
24.54
Papers
1445
Papers 1479
1 page of 148 pages (1,479 results)
Newest
Source
#1Elaine Y K Chow (CUHK: The Chinese University of Hong Kong)
#2C N Chan Juliana (CUHK: The Chinese University of Hong Kong)H-Index: 77
Source
Source
Source
#1Pablo Florenzano (UC: Pontifical Catholic University of Chile)H-Index: 3
#2Cristiana Cipriani (Sapienza University of Rome)H-Index: 17
Last.Jessica Pepe (Sapienza University of Rome)H-Index: 20
view all 7 authors...
Summary Phosphate metabolism is an evolving area of basic and clinical research. In the past 15 years, knowledge on disturbances of phosphate homoeostasis has expanded, as has the discovery of new targeted therapies. Hypophosphataemia might be the biochemical finding in several diseases, and its clinical evaluation should initially focus on the assessment of pathophysiological mechanisms leading to low serum phosphate concentrations. Clinical consequences of hypophosphataemia can involve multipl...
Source
#1Sylvia Kehlenbrink (Brigham and Women's Hospital)H-Index: 9
#2Philippa Boulle (MSF: Médecins Sans Frontières)H-Index: 4
Source
#1Jane A. Cauley (University of Pittsburgh)H-Index: 145
#2Lora Giangregorio (UW: University of Waterloo)H-Index: 29
Summary The purpose of this Review is to examine the associations between physical activity and skeletal health, with an emphasis on observational studies with fracture outcomes and randomised controlled trials (RCTs) of physical activity interventions in adults older than 40 years. In general, increased physical activity—primarily leisure time activity or moderate or vigorous physical activity—is associated with a 1–40% lower risk of hip and all fractures. The primary limitation of these studie...
Source
#1Arsene F Hobabagabo (NIH: National Institutes of Health)
#2Anne E. Sumner (NIH: National Institutes of Health)H-Index: 29
Source
#1Hertzel C. Gerstein (HHS: Hamilton Health Sciences)H-Index: 93
#2Robert G. Hart (Population Health Research Institute)H-Index: 83
Last.T. Temelkova-KurktschievH-Index: 20
view all 29 authors...
Summary Background Cardiovascular outcome trials have suggested that glucagon-like peptide 1 (GLP-1) receptor agonists might reduce strokes. We analysed the effect of dulaglutide on stroke within the researching cardiovascular events with a weekly incretin in diabetes (REWIND) trial. Methods REWIND was a multicentre, randomised, double-blind, placebo-controlled trial done at 371 sites in 24 countries. Men and women (aged ≥50 years) with established or newly detected type 2 diabetes whose HbA1c w...
1 CitationsSource
#1Medha N. Munshi (BIDMC: Beth Israel Deaconess Medical Center)H-Index: 18
#2Joshua J. Neumiller (Washington State University Spokane)H-Index: 21
Source
12345678910
Top fields of study
Internal medicine
Endocrinology
Type 2 diabetes
Population
Diabetes mellitus
Medicine